2022 White Paper | 2022 Annual Meeting | Supporting a Patient-Centric Approach to Dose Optimization in Oncology: The Essential Role of Patient-Reported Outcomes (PROs) Read more
2022 White Paper | 2022 Annual Meeting | Impact of the COVID-19 Pandemic Mitigation Strategies on Cancer Clinical Trials Read more
2022 White Paper | Accelerating Investigation of New Therapies in Earlier Metastatic Treatment Settings Read more
2022 White Paper | Circulating Tumor DNA in Development of Therapies for Cancer: An Evidentiary Roadmap to an Early Endpoint for Regulatory Decision-Making Read more
2022 White Paper | Multi-Cancer Early Detection Screening Tests: Considerations for Use of Real-World Data Read more
2022 White Paper | Expedited Development of Diagnostics for Therapies Targeting Rare Biomarkers or Indications Read more
2021 White Paper | 2021 Annual Meeting | Assessing the Use of ctDNA as an Early Endpoint in Early-Stage Disease Read more
